| For: | Iqbal K, Banga A, Arif TB, Rathore SS, Bhurwal A, Naqvi SKB, Mehdi M, Kumar P, Salklan MM, Iqbal A, Ahmed J, Sharma N, Lal A, Kashyap R, Bansal V, Domecq JP. Anticoagulant use before COVID-19 diagnosis prevent COVID-19 associated acute venous thromboembolism or not: A systematic review and meta-analysis. World J Methodol 2024; 14(3): 92983 [PMID: 39310244 DOI: 10.5662/wjm.v14.i3.92983] |
|---|---|
| URL: | https://www.wjgnet.com/2220-315X/full/v14/i3/92983.htm |
| Number | Citing Articles |
| 1 |
José Miguel Rivera‐Caravaca, Freddy Frost, Francisco Marín, Gregory Y. H. Lip. Impact of prior oral anticoagulation therapies on post‐discharge outcomes after COVID‐19: Results from a global federated health network analysis. European Journal of Clinical Investigation 2024; 54(12) doi: 10.1111/eci.14299
|
| 2 |
Amos Lal, Aysun Tekin, Guilherme Leite B. Goncalves, Erica Portner, John G. Park. Continuation of direct oral anticoagulants versus warfarin during critical illness: bleeding and clinical outcomes in a multicenter ICU cohort. Journal of Thrombosis and Thrombolysis 2026; doi: 10.1007/s11239-026-03376-3
|